Skip to main content

CLC Bio Develops Informatics Plug-in for Symphogen

NEW YORK (GenomeWeb News) – CLC Bio has developed a software plug-in to work with Symphogen's antibody identification system, the Danish informatics company said today.

CLC developed a plug-in for its Main Workbench that is aimed at optimizing Symphogen’s Symplex technology for high-throughput antibody identification.

Jannick Bendsten, CLC Bio’s director of consulting services, said that the new plug-in is designed to analyze sequencing data coming from research projects conducted using the Symplex system, and to integrate that data into an end-to-end workflow.

Financial terms of the agreement were not released.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.